Investigational dopaminergic cell replacement therapy shows safety and preliminary motor improvements in early-phase Parkinson disease clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results